Unknown NA INTERVENTIONAL 2-arm NCT03360279

DCB for Dialysis Access Stent Graft Restenosis

A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis

Sponsor: National Taiwan University Hospital Hsin-Chu Branch

Conditions Arteriovenous Graft Drug-coated Balloon Hemodialysis Access Failure (Disorder) Stent-Graft Restenosis

Interventions DCB (paclitaxel-coated balloon) Regular balloon

Updated 6 times since 2017 Last updated: Nov 27, 2017 Started: Mar 5, 2017 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Arteriovenous Graft and Drug-coated Balloon and is currently ongoing. National Taiwan University Hospital Hsin-Chu Branch leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital Hsin-Chu Branch

Data source: National Taiwan University Hospital Hsin-Chu Branch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hsinchu, Taiwan